Compare Navan Inc. Class A Common Stock (NAVN) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Navan Inc. Class A Common Stock vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Navan Inc. Class A Common Stock trades at $23.63 (market cap $6.01B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.95 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 4.2× Navan Inc. Class A Common Stock's market cap, and Royalty Pharma plc Class A Ordinary Shares pays a 1.66% dividend while Navan Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Navan Inc. Class A Common Stock for 1 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| NAVN | RPRX | |
|---|---|---|
Market Cap | $6.01B | $25.27B |
Volume | 2,990,425 | 3,671,183 |
Sector | Technology | Health |
52-Week High | $30.58 | $63.96 |
52-Week Low | $8.51 | $35.44 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $5.36B | $32.50B |
Dividend Yield | — | 1.66% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Navan Inc. Class A Common Stock
Navan provides an AI-powered platform for business travel, payments, and expense management. Its tools support trip booking, policy controls, payment processing, expense reconciliation, and reporting.
Read more on NAVN →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
